Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

989
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
989
Protein-protein Interfaces02:04

Protein-protein Interfaces

14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Protein Networks02:26

Protein Networks

4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MOLGAECL: Molecular Graph Contrastive Learning via Graph Auto-Encoder Pretraining and Fine-Tuning Based on Drug-Drug Interaction Prediction.

Journal of chemical information and modeling·2025
Same author

Integrated Knowledge Graph and Drug Molecular Graph Fusion via Adversarial Networks for Drug-Drug Interaction Prediction.

Journal of chemical information and modeling·2024
Same author

MRGCDDI: Multi-Relation Graph Contrastive Learning Without Data Augmentation for Drug-Drug Interaction Events Prediction.

IEEE journal of biomedical and health informatics·2024
Same author

A new species of Melanospora on truffles from China.

Mycologia·2012
Same author

[Effects of MSCs on the progression of atherosclerosis plaque in ApoE-knock out mice].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology·2012
Same author

Prospective ECG-gated 320-row CT angiography of the whole aorta and coronary arteries.

European radiology·2012

Related Experiment Video

Updated: Jan 17, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.1K

KGMAEDDI: Knowledge Graph and Molecular-Graph Masked Autoencoder for Drug-Drug Interaction Prediction.

Yu Li, Zhu-Hong You, Yuan Yang

    IEEE Journal of Biomedical and Health Informatics
    |September 18, 2025
    PubMed
    Summary

    This study introduces KGMAEDDI, a new framework for predicting drug-drug interactions (DDIs) by combining molecular structures and knowledge graphs. KGMAEDDI improves DDI prediction accuracy by integrating diverse drug information.

    More Related Videos

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    1.3K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K

    Related Experiment Videos

    Last Updated: Jan 17, 2026

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
    07:35

    A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

    Published on: October 13, 2023

    2.1K
    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    1.3K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K

    Area of Science:

    • Pharmacology
    • Bioinformatics
    • Computational Chemistry

    Background:

    • Drug-drug interaction (DDI) prediction is crucial for safe drug development.
    • Previous methods often ignored drug molecular structures or biomedical knowledge graph (KG) relationships.
    • Integrating both structural and semantic information is needed for accurate DDI prediction.

    Purpose of the Study:

    • To propose KGMAEDDI, a novel framework for DDI prediction.
    • To effectively integrate molecular structures and KG semantic knowledge.
    • To improve the accuracy and robustness of DDI prediction models.

    Main Methods:

    • Utilized a message-passing neural network for drug molecular structure feature extraction.
    • Employed a knowledge-aware attention network for KG semantic representation learning.
    • Integrated modalities using a masked autoencoder and bi-directional cross-attention for mutual reconstruction and alignment.

    Main Results:

    • KGMAEDDI demonstrated superior performance over state-of-the-art baselines on the DrugBank dataset.
    • The framework achieved high accuracy in both binary and multi-class DDI prediction settings.
    • The results validate the effectiveness of integrating structural and semantic information for DDI prediction.

    Conclusions:

    • KGMAEDDI successfully integrates molecular structures and KG semantic knowledge for enhanced DDI prediction.
    • The proposed fusion strategy effectively aligns drug representations in a shared latent space.
    • This approach offers a promising direction for advancing computational DDI prediction.